tirzepatide taken off market Experts warn about dangers of black weight loss meds The Food and Drug Administration

The drug tirzepatide , a dual-agonist for two gut hormones (GLP-1 and GIP), has a unique property that sets it apart from all other weight loss methods

No, fast food does not chemically block injectable GLP-1 medications

Cardiovascular outcome trials in patients with T2D have demonstrated the efficacy of GLP-1 RAs in reducing major adverse cardiovascular events, including cardiovascular death, MI and stroke, regardless of glycaemic control

[DOI] [PubMed] [Google Scholar] 438.Lewis EJ, Hunsicker LG, Clarke WR, et al

The underlying science supporting semaglutide is robust

Many people notice them from time to time, and for most, they fade with simple adjustments